Very red day for Aclaris Therapeutics stock price after -5.82% fall in Friday trading session
(Updated on Nov 26, 2021)
Sell candidate since 2021-11-02 Loss -23.42% PDF
The Aclaris Therapeutics stock price fell by -5.82% on the last day (Friday, 26th Nov 2021) from $13.40 to $12.62. During the day the stock fluctuated 6.77% from a day low at $12.40 to a day high of $13.24. The price has fallen in 8 of the last 10 days and is down by -17.25% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -29 thousand shares and in total, 216 thousand shares were bought and sold for approximately $2.73 million.
The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($14.79) are considered to be a "second chance" to get out. According to the fan-theory $12.05 will represent the new bottom line of the next trend, but it is far too early to say this for certain.
Signals & Forecast
There are few to no technical positive signals at the moment. The Aclaris Therapeutics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $13.35 and $15.78. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, November 01, 2021, and so far it has fallen -31.75%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.84 between high and low, or 6.77%. For the last week, the stock has had a daily average volatility of 7.02%.
Aclaris Therapeutics is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.
Is Aclaris Therapeutics stock A Buy?
Aclaris Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -4.989
Predicted Opening Price for Aclaris Therapeutics of Monday, November 29, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price November 29, 2021||Current price|
Remember To Visit Our YouTube Channel
On Nov 15, 2021 "HC Wainwright" gave "$49.00" rating for ACRS. The price target was changed from $14.90 to 0.1%.
ACRS Insider Trading
|Nov 01, 2021||Buy||8 276||Foresite Capital Management Iii, Llc||Common Stock|
|Nov 01, 2021||Sell||1 954 904||Foresite Capital Management Iii, Llc||Common Stock|
|Sep 01, 2021||Sell||1 041||Monahan Joseph||Common Stock|
|Sep 01, 2021||Buy||2 333||Monahan Joseph||Common Stock|
|Sep 01, 2021||Sell||2 333||Monahan Joseph||Restricted Stock Units|
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.